DJ Biogen Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ slid 1.39% to $192.62 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.30% to 7,405.73 and the Dow Jones Industrial Average falling 0.16% to 50,786.01.
This was the stock's second consecutive day of losses.
Biogen Inc. closed 6.48% short of its 52-week high of $205.97, which the company reached on May 13th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.26% to $232.16, Pfizer Inc. $(PFE)$ fell 1.61% to $25.62, and AbbVie Inc. $(ABBV)$ fell 1.83% to $223.07.
Trading volume (1.1 M) remained 105,024 below its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 8, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 08, 2026 16:58 ET (20:58 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments